Analyze Diet
Rapid communications in mass spectrometry : RCM2003; 17(4); 320-329; doi: 10.1002/rcm.909

In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.

Abstract: The in vivo phase I biotransformation of 17 alpha-methyltestosterone in the horse leads to the formation of a complex mixture of regio- and stereoisomeric C(20)O(2), C(20)O(3) and C(20)O(4) metabolites, excreted in urine as glucuronide and sulphate phase II conjugates. The major pathways of in vivo metabolism are the reduction of the A-ring (di- and tetrahydro), epimerisation at C-17 and oxidations mainly at C-6 and C-16. Some phase I metabolites have been identified previously by positive ion electron ionisation capillary gas chromatography/mass spectrometry (GC/EI + MS) mainly from the characteristic fragmentation patterns of their methyloxime-trimethylsilyl ether (MO-TMS), enol-TMS or TMS ether derivatives. Following oral administration of 17 alpha-methyltestosterone to two castrated thoroughbred male horses, the glucuronic acid conjugates excreted in post-administration urine samples were selectively hydrolysed by E. coli beta-glucuronidase enzymes. Unconjugated metabolites and the steroid aglycones obtained after enzymatic deconjugation were isolated from urine by solid-phase extraction, derivatised as MO-TMS ethers and analysed by GC/EI + MS. In addition to some of the known metabolites previously identified from the characteristic mass spectral fragmentation patterns of 17 alpha-methyl steroids, some isobaric compounds exhibiting a diagnostic loss of 103 mass units from the molecular ions with subsequent losses of trimethylsilanol or methoxy groups and an absence of the classical D-ring fragment ion were detected. From an interpretation of their mass spectra, these compounds were identified as 17-hydroxymethyl metabolites, formed in vivo in the horse by oxidation of the 17-methyl moiety of 17 alpha-methyltestosterone. This study reports on the GC/EI + MS identification of these novel 17-hydroxymethyl C(20)O(3) and C(20)O(4) metabolites of 17 alpha-methyltestosterone excreted in thoroughbred horse urine.
Publication Date: 2003-02-06 PubMed ID: 12569442DOI: 10.1002/rcm.909Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the in vivo biotransformation of 17 alpha-methyltestosterone in horses, leading to the identification of new metabolites in equine urine using capillary gas chromatography/mass spectrometry technique.

Understanding the Metabolism of 17 alpha-methyltestosterone

  • According to the study, the in vivo phase I biotransformation of 17 alpha-methyltestosterone in horses results in a complex mixture of C(20)O(2), C(20)O(3), and C(20)O(4) metabolites which are excreted out through the urine as phase II conjugates of glucuronide and sulphates.
  • The primary metabolic pathways involve the reduction of the A-ring, epimerisation at C-17, and predominant oxidations at C-6 and C-16. These metabolic processes reflect how the pathway of 17 alpha-methyltestosterone is altered and metabolised in the horse’s body.

Identification of phase I Metabolites

  • Earlier phase I metabolites were identified by GC/EI + MS mainly from the fragmentation patterns of their MO-TMS, enol-TMS, or TMS ether derivatives. This system yields data on the structure and type of the metabolites produced.
  • The study administered 17 alpha-methyltestosterone orally to two castrated thoroughbred male horses and selectively hydrolysed the glucuronic acid conjugates excreted in post-administration urine samples using E. coli beta-glucuronidase enzymes.
  • Post the enzymatic deconjugation, the metabolites and steroid aglycones were isolated from the urine and analysed by GC/EI + MS.

Identification of New Metabolites

  • The research discovered new metabolites, presenting a loss of 103 mass units from the molecular ions with losses of trimethylsilanol or methoxy groups and an absence of the classical D-ring fragment ion.
  • The mass spectral data identified these compounds as 17-hydroxymethyl metabolites. These were formed in vivo in horses by the oxidation of the 17-methyl moiety of 17 alpha-methyltestosterone.
  • This significant finding underscores the viability of using GC/EI + MS to identify these new C(20)O(3) and C(20)O(4) 17-hydroxymethyl metabolites of 17 alpha-methyltestosterone in thoroughbred horse urine.

Cite This Article

APA
Dumasia MC. (2003). In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom, 17(4), 320-329. https://doi.org/10.1002/rcm.909

Publication

ISSN: 0951-4198
NlmUniqueID: 8802365
Country: England
Language: English
Volume: 17
Issue: 4
Pages: 320-329

Researcher Affiliations

Dumasia, M C
  • Department of Drug Metabolism, Research Division, Horseracing Forensic Laboratory Ltd., PO Box 150, Newmarket Road, Fordham, Ely CB7 5WP, UK. mdumasia@hfl.co.uk

MeSH Terms

  • Animals
  • Biotransformation
  • Gas Chromatography-Mass Spectrometry / methods
  • Horses / urine
  • Male
  • Methyltestosterone / analogs & derivatives
  • Methyltestosterone / metabolism
  • Methyltestosterone / pharmacokinetics
  • Methyltestosterone / urine
  • Molecular Structure

Citations

This article has been cited 0 times.